Atlas Trials

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Clinical trial NCT00510965 · COMPLETED

Trial details

NCT number
NCT00510965
Sponsor
University Hospital, Bonn
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Choroidal Neovascularization
Start date
2007-08-01
Primary completion
2010-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.